Cargando…
KDELR2 promotes breast cancer proliferation via HDAC3‐mediated cell cycle progression
BACKGROUND: Histone deacetylases (HDACs) engage in the regulation of various cellular processes by controlling global gene expression. The dysregulation of HDACs leads to carcinogenesis, making HDACs ideal targets for cancer therapy. However, the use of HDAC inhibitors (HDACi) as single agents has b...
Autores principales: | Wei, Haoran, Ma, Wenhao, Lu, Xiaofei, Liu, Haiying, Lin, Kashuai, Wang, Yinghui, Ye, Zijian, Sun, Linchong, Huang, Zhitong, Pan, Tingting, Zhou, Zilong, Cheng, Eric Y., Zhang, Huafeng, Gao, Ping, Zhong, Xiuying |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8441056/ https://www.ncbi.nlm.nih.gov/pubmed/34146461 http://dx.doi.org/10.1002/cac2.12180 |
Ejemplares similares
-
KDELR1 Is an Independent Prognostic Predictor and Correlates With Immunity in Glioma
por: Yuan, Yifan, et al.
Publicado: (2022) -
A Golgi-based KDELR-dependent signalling pathway controls extracellular matrix degradation
por: Ruggiero, Carmen, et al.
Publicado: (2014) -
IMPAD1 and KDELR2 drive invasion and metastasis by enhancing Golgi-mediated secretion.
por: Bajaj, Rakhee, et al.
Publicado: (2020) -
Transcriptomics of a KDELR1 knockout cell line reveals modulated cell adhesion properties
por: Blum, Andrea, et al.
Publicado: (2019) -
Metformin sensitises hepatocarcinoma cells to methotrexate by targeting dihydrofolate reductase
por: Wang, Yinghui, et al.
Publicado: (2021)